Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

Market Cap	3.09B -22.8%
Revenue (ttm)	625.30M -5.3%
Net Income	-11.56M
EPS	-0.06
Shares Out	198.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.27 (1.73%)
Ex-Dividend Date	Jun 6, 2025

Volume	1,458,880
Open	15.75
Previous Close	15.79
Day's Range	15.55 - 15.82
52-Week Range	15.15 - 23.51
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 1,119
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603896

Financial Performance

In 2025, SHA:603896's revenue was 640.18 million, a decrease of -9.21% compared to the previous year's 705.11 million. Earnings were 18.17 million, a decrease of -89.58%.